Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Results>WUXI BIO Annual NP Dips 1.3% to RMB3.36B; Nil Div.
Recommend 14 Positive 18 Negative 8 |
||||
|
||||
|
WUXI BIO (02269.HK) announced its full-year results for the period ending December 2024. Revenue amounted to RMB18.675 billion, up 9.6% YoY. It recorded a net profit of RMB3.356 billion, down 1.3% YoY, with an EPS of RMB0.82. No final dividend was declared, consistent with that in the same period of last year. During the period, gross profit added 12.1% YoY to RMB7.65 billion, with the gross profit margin gaining from 40.1% in the same period of last year to 41%. The increases were mainly due to the efficiency improvements driven from WBS and digitalization, and also the improvements of the ramp-up impacts from the recently commissioned facilities in Europe and the U.S. as expected. AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
